Tech Company Financing Transactions

SynDevRx Funding Round

SynDevRx closed a $1.3 million financing round on 9/30/2010. Investors included private investors.

Transaction Overview

Company Name
Announced On
9/30/2010
Transaction Type
Venture Equity
Amount
$1,295,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
One Broadway 14th Floor
Cambridge, MA 02142
USA
Email Address
Overview
Our mission is to improve human health by developing polymeric prodrugs which deliver MetAP2 inhibitors to diseased tissues. The first two drug candidates we are developing have been previously shown to shrink tumors, inhibit angiogenesis and prevent metastasis in early clinical trials.
Profile
SynDevRx LinkedIn Company Profile
Social Media
SynDevRx Company Twitter Account
Company News
SynDevRx News
Facebook
SynDevRx on Facebook
YouTube
SynDevRx on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Bradley Carver
  Bradley Carver LinkedIn Profile  Bradley Carver Twitter Account  Bradley Carver News  Bradley Carver on Facebook
VP - Bus. Development
James Shanahan
  James Shanahan LinkedIn Profile  James Shanahan Twitter Account  James Shanahan News  James Shanahan on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/30/2010: SP Surgical venture capital transaction
Next: 9/30/2010: Tobira Therapeutics venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary